GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (FRA:Y230) » Definitions » Other Net Income (Loss)

Akanda (FRA:Y230) Other Net Income (Loss) : €-0.78 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Akanda Other Net Income (Loss)?

Akanda's Other Net Income (Loss) for the six months ended in Dec. 2024 was €-0.35 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.78 Mil.

Akanda's quarterly Other Net Income (Loss) increased from Dec. 2023 (€-23.24 Mil) to Jun. 2024 (€-0.43 Mil) and increased from Jun. 2024 (€-0.43 Mil) to Dec. 2024 (€-0.35 Mil).

Akanda's annual Other Net Income (Loss) declined from Dec. 2022 (€-3.23 Mil) to Dec. 2023 (€-26.19 Mil) but then increased from Dec. 2023 (€-26.19 Mil) to Dec. 2024 (€-0.79 Mil).

Akanda Other Net Income (Loss) Historical Data

The historical data trend for Akanda's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Other Net Income (Loss) Chart

Akanda Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial - -5.01 -3.23 -26.19 -0.79

Akanda Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only 0.31 -2.97 -23.24 -0.43 -0.35

Akanda Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akanda Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Akanda's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Akanda Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (FRA:Y230) » Definitions » Other Net Income (Loss)
Comparable Companies
OWPC PTPI CPMD ALID SHPH STEK YCBD INM UPC CBDY ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AKAN:USA
Address
1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU
Website
https://www.akandacorp.com
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.

Akanda Headlines

No Headlines